Larvol Delta - Bellerophon-Announces-FDA-Acceptance-of-Change-to-Ongoing-Phase-3-REBUILD-Study-of-INOpulse-for-Treatment-of-Fibrotic-Interstitial-Lung-Disease

INOpulse (nitric oxide) - Bellerophon Therap

https://www.globenewswire.com/news-release/2022/09/27/2523327/0/en/Bellerophon-Announces-FDA-Acceptance-of-Change-to-Ongoing-Phase-3-REBUILD-Study-of-INOpulse-for-Treatment-of-Fibrotic-Interstitial-Lung-Disease.html

Sep 27, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next